Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis

Journal of Dairy Science

Volumn 94, Issue 12, 2011, Pages 6203-6215

  Schukken, Y H ^a   Bennett, G J ^a   Zurakowski, M J ^a   Sharkey, H L ^a   Rauch, B J ^a   Thomas, M J ^b   Ceglowski, B ^c   Saltman, R L ^d   Belomestnykh, N ^a   Zadoks, R N ^a,e,f  

^a Department of Molecular Biology and Genetics   (United States)

^b Countryside Veterinary Clinic ^*  (United States)

^c Rupert Veterinary Clinic   (United States)

^d ZOETIS   (United States)

^e MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Ceftiofur hydrochloride; Escherichia coli; Gram negative mastitis; Klebsiella

Indexed keywords

ANTIINFECTIVE AGENT; CEFTIOFUR; CEPHALOSPORIN DERIVATIVE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BOVINE MASTITIS; CATTLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; GRAM NEGATIVE INFECTION; KLEBSIELLA INFECTION; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; KLEBSIELLA INFECTIONS; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE;

EID: 82155192872     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2011-4290     Document Type: Article

References (41)

1. Barkema H.W., Schukken Y.H., Lam T.J.G.M., Beiboer M.L., Wilmink H., Benedictus G., Brand A. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J. Dairy Sci. 1998, 81:411-419.
2. Bengtsson B., Unnerstad H.E., Ekman T., Artursson K., Nilsson-Ost M., Waller K.P. Antimicrobial susceptibility of udder pathogens from cases of acute clinical mastitis in dairy cows. Vet. Microbiol. 2009, 136:142-149.
3. Bradley A.J., Green M.J. A study of the incidence and significance of intramammary enterobacterial infections acquired during the dry period. J. Dairy Sci. 2000, 83:1957-1965.
4. Breen J.E., Green M.J., Bradley A.J. Quarter and cow risk factors associated with the occurrence of clinical mastitis in dairy cows in the United Kingdom. J. Dairy Sci. 2009, 92:2551-2561.
5. Dogan B., Klaessig S., Rishniw M., Almeida R.A., Oliver S.P., Simpson K., Schukken Y.H. Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Vet. Microbiol. 2006, 116:270-282.
6. Erskine R.J., Bartlett P.C., VanLente J.L., Phipps C.R. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle. J. Dairy Sci. 2002, 85:2571-2575.
7. Erskine R.J., Eberhart R.J., Hutchinson L.J., Spencer S.B., Campbell M.A. Incidence and types of clinical mastitis in dairy herds with high and low somatic cell counts. J. Am. Vet. Med. Assoc. 1988, 192:761-765.
8. Erskine R.J., Walker R.D., Bolin C.A., Bartlett P.C., White D.G. Trends in antibacterial susceptibility of mastitis pathogens during a seven-year period. J. Dairy Sci. 2002, 85:1111-1118.
9. Erskine R.J., Wilson R.C., Tyler J.W., McClure K.A., Nelson R.S., Spears H.J. Ceftiofur distribution in serum and milk from clinically normal cows and cows with experimental Escherichia coli-induced mastitis. Am. J. Vet. Res. 1995, 56:481-485.
10. FDA. 2005. Approved animal drug producrts. Accessed Oct, 3, 2011. http://www.fda.gov/downloads/AnimalVeterinary/Products/ApprovedAnimalDrugProducts/FOIADrugSummaries/ucm118051.pdf.
11. Gröhn Y.T., Wilson D.J., González R.N., Hertl J.A., Schulte H., Bennett G., Schukken Y.H. Effect of pathogen-specific clinical mastitis on milk yield in dairy cows. J. Dairy Sci. 2004, 87:3358-3374.
12. Hoeben B.D., Monfardini E., Burvenich C., Hamann J. Treatment of acute Escherichia coli mastitis in cows with enrofloxacin: Effect on clinical signs and chemiluminescence of circulating neutrophils. J. Dairy Res. 2000, 67:485-502.
13. Hogan J., Smith K.L. Coliform mastitis. Vet. Res. 2003, 34:507-519.
14. Lam T.J., Lipman L.J., Schukken Y.H., Gaastra W., Brand A. Epidemiological characteristics of bovine clinical mastitis caused by Staphylococcus aureus and Escherichia coli studied by DNA fingerprinting. Am. J. Vet. Res. 1996, 57:39-42.
15. Leininger D.J., Roberson J.R., Elvinger F., Ward D., Akers R.M. Evaluation of frequent milkout for treatment of cows with experimentally induced Escherichia coli mastitis. J. Am. Vet. Med. Assoc. 2003, 222:63-66.
16. Locatelli C., Caronte I., Scaccabarozzi L., Migliavacca R., Pagani L., Moroni P. Extended-spectrum beta-lactamase production in E. coli strains isolated from clinical bovine mastitis. Vet. Res. Commun. 2009, 33(Suppl. 1):141-144.
17. Luby C.D., Middleton J.R. Efficacy of vaccination and antibiotic therapy against Staphylococcus aureus mastitis in dairy cattle. Vet. Rec. 2005, 157:89-90.
18. Munoz M.A., Welcome F.L., Schukken Y.H., Zadoks R.N. Molecular epidemiology of two Klebsiella pneumoniae outbreaks on a dairy farm in New York State. J. Clin. Microbiol. 2007, 45:3964-3971.
19. Munoz M.A., Zadoks R.N. Short communication: Patterns of fecal shedding of Klebsiella by dairy cows. J. Dairy Sci. 2007, 90:1220-1224.
20. Nam H.M., Lim S.K., Kang H.M., Kim J.M., Moon J.S., Jang K.C., Kim J.M., Joo Y.S., Jung S.C. Prevalence and antimicrobial susceptibility of gram-negative bacteria isolated from bovine mastitis between 2003 and 2008 in Korea. J. Dairy Sci. 2009, 92:2020-2026.
21. Laboratory Handbook on Bovine Mastitis 1999, National Mastitis Council, National Mastitis Council, Madison, WI.
22. Olde Riekerink R.G., Barkema H.W., Kelton D.F., Scholl D.T. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 2008, 91:1366-1377.
23. Oliver S.P., Gillespie B.E., Jayarao B.M. Detection of new and persistent Streptococcus uberis and Streptococcus dysgalactiae intramammary infections by polymerase chain reaction-based DNA fingerprinting. FEMS Microbiol. Lett. 1998, 160:69-73.
24. Paulin-Curlee G.G., Singer R.S., Sreevatsan S., Isaacson R., Reneau J., Foster D., Bey R. Genetic diversity of mastitis-associated Klebsiella pneumoniae in dairy cows. J. Dairy Sci. 2007, 90:3681-3689.
25. Pfeifer Y., Cullik A., Witte W. Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int. J. Med. Microbiol. 2010, 300:371-379.
26. Phuektes P., Mansell P.D., Dyson R.S., Hooper N.D., Dick J.S., Browning G.F. Molecular epidemiology of Streptococcus uberis isolates from dairy cows with mastitis. J. Clin. Microbiol. 2001, 39:1460-1466.
27. Poutrel B., Stegemann M.R., Roy O., Pothier F., Tilt N., Payne-Johnson M. Evaluation of the efficacy of systemic danofloxacin in the treatment of induced acute Escherichia coli bovine mastitis. J. Dairy Res. 2008, 75:310-318.
28. Pyörälä S., Kaartinen L., Käck H., Rainio V. Efficacy of two therapy regimens for treatment of experimentally induced Escherichia coli mastitis in cows. J. Dairy Sci. 1994, 77:453-461.
29. Rantala M., Kaartinen L., Välimäki E., Stryrman M., Hiekkaranta M., Niemi A., Saari L., Pyörälä S. Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis. J. Vet. Pharmacol. Ther. 2002, 25:251-258.
30. Roberson J.R., Warnick L.D., Moore G. Mild to moderate clinical mastitis: Efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. J. Dairy Sci. 2004, 87:583-592.
31. Shpigel N.Y., Levin D., Winkler M., Saran A., Ziv G., Böttner A. Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli. J. Dairy Sci. 1997, 80:318-323.
32. Srinivasan V., Gillespie B.E., Lewis M.J., Nguyen L.T., Headrick S.I., Schukken Y.H., Oliver S.P. Phenotypic and genotypic antimicrobial resistance patterns of Escherichia coli isolated from dairy cows with mastitis. Vet. Microbiol. 2007, 124:319-328.
33. Suojala L., Pohjanvirta T., Simojoki H., Myllyniemi A.L., Pitkälä A., Pelkonen S., Pyörälä S. Phylogeny, virulence factors and antimicrobial susceptibility of Escherichia coli isolated in clinical bovine mastitis. Vet. Microbiol. 2011, 147:383-388.
34. Suojala L., Simojoki H., Mustonen K., Kaartinen L., Pyörälä S. Efficacy of enrofloxacin in the treatment of naturally occurring acute clinical Escherichia coli mastitis. J. Dairy Sci. 2010, 93:1960-1969.
35. Todhunter D.A., Smith K.L., Hogan J.S., Schoenberger P.S. Gram-negative bacterial infections of the mammary gland in cows. Am. J. Vet. Res. 1991, 52:184-188.
36. Wenz J.R., Barrington G.M., Garry F.B., Dinsmore R.P., Callan R.J. Use of systemic disease signs to assess disease severity in dairy cows with acute coliform mastitis. J. Am. Vet. Med. Assoc. 2001, 218:567-572.
37. Wenz J.R., Garry F.B., Barrington G.M. Comparison of disease severity scoring systems for dairy cattle with acute coliform mastitis. J. Am. Vet. Med. Assoc. 2006, 229:259-262.
38. Wenz J.R., Garry F.B., Lombard J.E., Elia R., Prentice D., Dinsmore R.P. Efficacy of parenteral ceftiofur for treatment of systemically mild clinical mastitis in dairy cattle. J. Dairy Sci. 2005, 88:3496-3499.
39. White L.J., Schukken Y.H., Dogan B., Green L., Döpfer D., Chappell M.J., Medley G.F. Modelling the dynamics of intramammary E. coli infections in dairy cows: Understanding mechanisms that distinguish transient from persistent infections. Vet. Res. 2010, 41:13-21.
40. Young B., Platt D., Logue D., Ternent H., Fitzpatrick J. Bovine Staphylococcus aureus mastitis: strain recognition and dynamics of infection. J. Dairy Res. 2001, 68:377-388.
41. Zadoks R.N., Schukken Y.H. Use of molecular epidemiology in veterinary practice. Vet. Clin. North Am. Food Anim. Pract. 2006, 22:229-261.